Paclitaxel-loaded poly(γ-glutamic acid)-poly(lactide) nanoparticles as a targeted drug delivery system for the treatment of liver cancer
- 1 March 2006
- journal article
- research article
- Published by Elsevier in Biomaterials
- Vol. 27 (9) , 2051-2059
- https://doi.org/10.1016/j.biomaterials.2005.10.027
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Poly(N-vinylpyrrolidone)-block-poly(d,l-lactide) as a new polymeric solubilizer for hydrophobic anticancer drugs: in vitro and in vivo evaluationJournal of Controlled Release, 2004
- Camptothecin derivative-loaded poly(caprolactone-co-lactide)-b-PEG-b-poly(caprolactone-co-lactide) nanoparticles and their biodistribution in miceJournal of Controlled Release, 2004
- Crosslinking structures of gelatin hydrogels crosslinked with genipin or a water‐soluble carbodiimideJournal of Applied Polymer Science, 2004
- Biodistribution and anti-tumor efficacy of doxorubicin loaded glycol-chitosan nanoaggregates by EPR effectJournal of Controlled Release, 2003
- Crosslinking of biological tissues using genipin and/or carbodiimideJournal of Biomedical Materials Research Part A, 2003
- Poly(l-glutamic acid)–anticancer drug conjugatesAdvanced Drug Delivery Reviews, 2002
- Poly(glutamic Acid) for Biomedical ApplicationsCritical Reviews in Biotechnology, 2001
- A new class of polymerizable dextrans with hydrolyzable groups: hydroxyethyl methacrylated dextran with and without oligolactate spacerPolymer, 1997
- Characterization of the Taxol Binding Site on the MicrotubuleJournal of Biological Chemistry, 1995
- Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomesBiochimica et Biophysica Acta (BBA) - Biomembranes, 1994